Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-04-04FDA Approved: ACETAZOLAMIDE — Original Application (Zydus Lifesciences Limited)
FDA approved a generic acetazolamide product from Zydus Lifesciences Limited under an Original Application (ANDA211069).
-
FDA approval · 2023-03-29FDA Approved: BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Brimonidine tartrate ophthalmic solution 0.15% from Alembic Pharmaceuticals as an Original Application (ANDA) for lowering intr…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Safety and IOP-Lowering Effects of WB007 [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and intraocular pressure-lowering effects of WB007 in glaucoma and ocular hypertension. Results have been …
-
FDA approval · 2023-03-23FDA Approved: TIMOLOL MALEATE — Original Application (Aurobindo Pharma Limited)
FDA approves original ANDA for timolol maleate ophthalmic solution from Aurobindo Pharma Limited, enabling a generic version for lowering in…
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial comparing netarsudil 0.02% with ripasudil 0.4% in Japanese patients with primary open angle glaucoma or ocular hypert…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 multicenter trial comparing DE-126 ophthalmic solution to timolol in primary open-angle glaucoma or ocular hypertension has comple…
-
FDA approval · 2022-12-13FDA Approved: IYUZEH — Original Application (Thea Pharma Inc.)
FDA approved IYUZEH, latanoprost ophthalmic solution 0.005%, under an original NDA from Thea Pharma Inc. for reducing intraocular pressure i…
-
FDA approval · 2022-12-12FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's original application for a generic fixed-dose combination of brimonidine tartrate and timolol maleate ophthalmic…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 dose-response study evaluating NCX 470 versus latanoprost in open-angle glaucoma or ocular hypertension has completed with results p…
-
FDA approval · 2022-12-05FDA Approved: LATANOPROST — Supplemental Application (Somerset Therapeutics, LLC)
The FDA approved a supplemental application for latanoprost from Somerset Therapeutics, LLC. Latanoprost is used to lower intraocular pressu…
-
FDA approval · 2022-12-01FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Bimatoprost from Apotex Corp. under an Abbreviated New Drug Application (ANDA). The approval con…
-
FDA approval · 2022-11-22FDA Approved: TIMOLOL MALEATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for timolol maleate from Sandoz Inc, supporting an additional generic ophthalmic product. Timolol ma…
-
FDA approval · 2022-11-08FDA Approved: BIMATOPROST — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for bimatoprost from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos. [Phase 4]
Phase 4 trial update comparing preserved vs preservative-free latanoprost 0.005% in primary open-angle glaucoma and ocular hypertension pati…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: InnFocus MicroShunt Versus Trabeculectomy Study [NA]
A completed clinical trial comparing InnFocus MicroShunt to trabeculectomy for primary open angle glaucoma with results posted.
-
FDA approval · 2022-10-04FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved a generic combination product of brimonidine tartrate and timolol maleate for lowering intraocular pressure in glaucoma or ocul…
-
FDA approval · 2022-09-22FDA Approved: OMLONTI — Original Application (Ocuvex Therapeutics, Inc.)
The FDA approved OMLONTI (omidenepag isopropyl) from Ocuvex Therapeutics as an Original Application (NDA 215092) for reducing intraocular pr…
-
FDA approval · 2022-09-22FDA Approved: OMLONTI — Supplemental Application (Ocuvex Therapeutics, Inc.)
The FDA approved a supplemental application for OMLONTI (omidenepag isopropyl) from Ocuvex Therapeutics, expanding the approved use of the o…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Post Approval Study of the CyPass System [NA]
Post-approval study of the CyPass System has terminated; results posted in 2022.
-
FDA approval · 2022-09-19FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Gland Pharma Limited)
The FDA approved Gland Pharma Limited's generic dorzolamide hydrochloride and timolol maleate ophthalmic solution (ANDA 215520) for lowering…
-
FDA approval · 2022-09-13FDA Approved: TIMOLOL MALEATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' original ANDA for Timolol Maleate ophthalmic solution, sanctioning a generic treatment option for open…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost [Phase 4]
Phase 4 trial comparing two trabecular micro-bypass stents (iStent Inject) to travoprost in adults with open-angle glaucoma and related ocul…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication [Phase 4]
A Phase 4 trial updating on the use of two second-generation trabecular micro-bypass stents in glaucoma patients on one hypotensive medicati…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents [Phase 4]
Phase 4 trial update evaluating two trabecular micro-bypass stents plus postoperative travoprost in open-angle glaucoma patients already usi…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent [Phase 4]
Phase 4 clinical trial update evaluating a suprachoroidal stent in open-angle glaucoma patients treated with two topical hypotensive medicat…